title: Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guérin instillation?
abstract: We report a case of vitiligo in a 63-year-old man who had undergone intravesical bacillus Calmette-Guérin treatment following removal of a superficial transitional cell carcinoma in the bladder.
authors.affiliation: Department of Urology, Haukeland University Hospital, Bergen, Norway. Christian.Beisland@haukeland.no
authors.forename: Christian
authors.initials: C
authors.lastname: Beisland
authors.forename: Dag Sollesnes
authors.initials: DS
authors.lastname: Holsen
mesh_terms: D000283:Administration, Intravesical; D001323:Autoantibodies / Q000097:blood*; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014820:Vitiligo / Q000139:chemically induced / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D001500:BCG Vaccine